Blog
Pioglitazone Is Safe and Effective Option For Patients with Type 2 Diabetes and NASH
Many patients with prediabetes or Type 2 Diabetes Mellitus (T2DM) are not diagnosed with Nonalcoholic steatohepatitis (NASH), a disease that is the second cause of liver transplantation in the United States.
UF Diabetes: The Next Generation
By Morgan Sherburne A new vanguard of researchers continues UF’s tradition of pushing the boundaries of diabetes research and care. This vanguard includes Michael Haller, MD; Clayton Mathews, PhD; Jing Chen, MD, PhD; Todd Brusko, PhD; Laura Jacobsen, MD; and Kenneth Cusi, MD. Photos by Jesse…
UF Diabetes Spotlight
The new UF Diabetes Institute brings together more than 100 researchers and physicians with the ultimate goal of providing effective therapies and improving health for patients. Intersecting Paths Originally appeared in Explore UF Research, April 2015 Griffin Mangan Amy and Mike Mangan knew immediately…